Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study. by Sadarangani, M et al.
Sadarangani, M; Seaton, C; Scott, JA; Ogutu, B; Edwards, T; Prins,
A; Gatakaa, H; Idro, R; Berkley, JA; Peshu, N; Neville, BG; Newton,
CR (2008) Incidence and outcome of convulsive status epilepticus in
Kenyan children: a cohort study. Lancet neurology, 7 (2). pp. 145-50.
ISSN 1474-4422 DOI: https://doi.org/10.1016/S1474-4422(07)70331-
9
Downloaded from: http://researchonline.lshtm.ac.uk/1440366/
DOI: 10.1016/S1474-4422(07)70331-9
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
http://neurology.thelancet.com   Vol 7   February 2008 145
Articles
Incidence and outcome of convulsive status epilepticus in 
Kenyan children: a cohort study
Manish Sadarangani, Claire Seaton, J Anthony G Scott, Bernhards Ogutu, Tansy Edwards, Agnes Prins, Hellen Gatakaa, Richard Idro, 
James A Berkley, Norbert Peshu, Brian G Neville, Charles R Newton
Summary
Background Convulsive status epilepticus (CSE) is the most common neurological emergency in childhood and is often 
associated with fever. In sub-Saharan Africa, the high incidence of febrile illnesses might inﬂ uence the incidence and 
outcome of CSE. We aimed to provide data on the incidence, causes, and outcomes of childhood CSE in this region.
Methods Between March, 2006, and June, 2006, we studied all children who had been admitted with CSE to a Kenyan 
rural district hospital in 2002 and 2003. Conﬁ rmed CSE had been observed directly; probable CSE was inferred from 
convulsions on arrival, requirement for phenobarbital or phenytoin, or coma with a recent history of seizures. We 
estimated the incidence with linked demographic surveillance, and risk factors for death and neurological sequelae 
were analysed by multivariable analysis.
Findings Of 388 episodes of CSE, 155 (40%) were conﬁ rmed CSE and 274 (71%) were caused by an infection. The 
incidence of conﬁ rmed CSE was 35 (95% CI 27–46) per 100 000 children per year overall, and was 52 (21–107) and 
85 (62–114) per 100 000 per year in children aged 1–11 months and 12–59 months, respectively. The incidence of all 
CSE was 268 (188–371) and 227 (189–272) per 100 000 per year in these age-groups. 59 (15%) children died in hospital, 
81 (21%) died during long-term follow-up, and 46 (12%) developed neurological sequelae. Mortality of children with 
conﬁ rmed CSE while in hospital was associated with bacterial meningitis (adjusted relative risk [RR]=2·6; 95% CI 
1·4–4·9) and focal onset seizures (adjusted RR=2·4; 1·1–5·4), whereas neurological sequelae were associated with 
hypoglycaemia (adjusted RR=3·5; 1·8–7·1) and age less than 12 months (adjusted RR=2·5; 1·2–5·1).
Interpretation Prevention of infections and appropriate early management of seizures might reduce the incidence 
and improve the outcome of CSE in children in sub-Saharan Africa.
Introduction
Convulsive status epilepticus (CSE) is the most common 
childhood neurological emergency in developed countries 
and can lead to neurocognitive sequelae and death.1,2 The 
incidence of CSE in London, UK, has been reported as 
18–20 per 100 000 per year in children of less than 16 years 
old, with higher rates in the ﬁ rst few years of life.3 These 
rates were similar in other studies in developed 
countries.4
In the London study, one third of childhood CSE was 
attributable to febrile seizures with a benign short-term 
outcome.3 However, 19% (18/95) of children with CSE 
associated with fever had a CNS infection; acute bacterial 
meningitis was particularly common and was associated 
with a higher risk of mortality.3 Seizures with fever are 
common in children admitted to hospitals in sub-Saharan 
Africa,5 particularly in malaria-endemic areas where CSE is 
well recognised. Furthermore, socioeconomic deprivation 
and non-white ethnic origin were independently associated 
with an increased incidence of CSE in the London study 
(Chin R, personal communication). These factors suggest a 
higher incidence would be expected in sub-Saharan Africa 
than in London. Finally, restricted access to anti epileptic 
drugs, particularly parenteral pheno barbital,6 might lead to 
higher mortality and morbidity in this region.
We assessed the incidence of CSE in children admitted 
to a rural Kenyan hospital in a malaria-endemic area. We 
also examined the clinical and laboratory features of 
these children, and identiﬁ ed risk factors for both death 
and neurological sequelae. 
Methods
Patients and procedures
Kiliﬁ  District Hospital (KDH) is located on the Kenyan 
coast and has two seasonal peaks for malaria admissions, 
in January and July. KDH is the main district-level 
government inpatient facility, serving a community of 
about 100 000 children. Staﬀ  in a Kenya Medical Research 
Institute (KEMRI) Centre at the hospital provide clinical 
cover 24 h a day. For every child admitted, standard 
clinical and laboratory data are entered into a computer 
database. The hospital is situated within an 891 km² 
demographic surveillance system (DSS) area,7 from 
which about 80% of all admissions are derived. This area 
was mapped in the year 2000 by ﬁ eldworkers on 
motorcycles and on foot: every building was registered by 
its global positioning system coordinates, and a census 
deﬁ ned the resident population. All subsequent births, 
deaths, and migration events are monitored by 
ﬁ eldworkers who visit every participating household 
about once every 4 months. The housing register is also 
updated every 4 months by remapping.
We used the database of admissions to identify all 
children who were admitted between Jan 1, 2002, and 
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Dec 31, 2003, who were between 1 month and 13 years of 
age and who had a history of seizures or a diagnosis of 
epilepsy, febrile seizures, or encephalopathy. We reviewed 
case notes of these children, and episodes of CSE were 
identiﬁ ed and classiﬁ ed as conﬁ rmed CSE or probable 
CSE. Conﬁ rmed CSE was deﬁ ned according to the 
International League Against Epilepsy criteria8 (ie, a 
seizure that lasted for 30 min or longer, or intermittent 
seizures that lasted for less than 30 min from which 
consciousness was not regained for at least 1 h, as 
documented by medical or nursing staﬀ ). Probable CSE 
was deﬁ ned by any one of the following criteria: 
convulsions on arrival to hospital; use of phenytoin or 
phenobarbital to stop seizures after the failure of two 
doses of the ﬁ rst-line medication (diazepam, paraldehyde, 
or both); coma, deﬁ ned as a Blantyre coma score of 2 or 
less,9 on admission and a history of more than one 
seizure in the 30 min before presentation; or coma on 
admission and a history of more than ten seizures in the 
24 h before presentation.
Clinicians entered medical history and examination 
ﬁ ndings at admission into the computer database using 
a standard form. Full blood count, malaria slide, plasma 
glucose, venous blood gas, and blood culture tests were 
done for all children at admission. A Coulter MDII-18 
counter (Beckman-Coulter, Fullerton CA, USA) was used 
for full blood counts. For diagnosis of malaria, thick and 
thin blood smears were examined at ×1000 magniﬁ cation. 
Glucose was assayed with a GM7 analyser (Analox Ltd, 
London, UK), and blood gas was assayed with an IL 1620 
analyser (Instrumentation Laboratory, Lexington, MA, 
USA). Blood cultures were processed with a BACTEC 
9050 system (Becton Dickinson, Franklin Lakes, NJ, 
USA) and examined by routine microbiological methods. 
All coagulase-negative staphylococci, bacilli, and 
micrococci were classiﬁ ed as contaminants. The CSF 
leucocyte count was recorded with a modiﬁ ed Neubauer 
counting chamber. For culture, CSF was inoculated on to 
plates of 7% horse-blood agar and 5% chocolate-and-
blood agar and processed by standard microbiological 
techniques. The normal ranges used for CSF variables 
have been described previously.5
Lumbar puncture was done in children with indications 
of possible meningitis.5 Diagnoses were recorded for all 
patients according to the International Classiﬁ cation of 
Diseases, ninth revision.10 A primary clinical diagnosis of 
malaria was assigned if the child had Plasmodium 
falciparum asexual parasitaemia and no other causes 
could be identiﬁ ed. A diagnosis of febrile seizures was 
made for patients who had neither parasitaemia nor 
evidence of meningitis or encephalitis. 
KEMRI-trained nursing staﬀ  used a standard form to 
document all seizures, which were most commonly 
recognised as motor convulsions. A standard protocol for 
emergency seizure management was used: children with 
seizures lasting more than 5 min received intravenous 
diazepam followed by intramuscular paraldehyde 10 min 
later, if required. At 20–30 min, intravenous phenobarbital 
was given, with intravenous phenytoin used subsequently 
for refractory episodes. Management of children in 
continuing CSE was decided on an individual basis by a 
senior clinician. Children with three or more seizures of 
less than 5 min within 1 h were given phenobarbital to 
prevent further seizures, because artiﬁ cial ventilation 
was not available. All children with CSE received quinine 
and broad-spectrum antibiotics.
Children who had an episode of CSE in 2002 or 2003 
were visited at home between March, 2006, and June, 
2006, and screened with the Ten Questions question-
naire11,12 for neurocognitive impairment. Children who 
were positive on this screen were invited for further 
assessment at KDH. If the child had died, the cause of 
death was established through a verbal autopsy13 with the 
parents or guardians.
Statistical analysis
Data were recorded with EpiData (version 3.02) and 
analysed with Stata (version 8.0). If a child had multiple 
admissions to KDH with CSE during the study period, 
only the ﬁ rst episode was included. We used Pearson’s χ² 
test (two-tailed) to compare categorical variables, the 
Student’s t test to compare the means of normally 
distributed data, and the Mann-Whitney test to compare 
non-parametric data.
The incidence of hospital admission with CSE was 
estimated for the subgroup of children who lived in the 
DSS area and presented at KDH between April 16, 2002, 
and Dec 31, 2003, because during this time these 
admissions were electronically linked to a DSS database. 
Estimates of the ages and of the numbers of children of 
each sex were made at the midpoint of this interval 
(Feb 22, 2003) by ﬁ tting a linear regression line through 
the population counts (on a log scale) from each of ten 
enumeration rounds between September, 2000, and 
May, 2006. Conﬁ rmed and probable cases were combined 
to estimate overall incidence rates. Conﬁ dence intervals 
and rate comparisons were calculated with Poisson 
regression analysis. 
Risk ratios for mortality and neurological sequelae in 
children with conﬁ rmed CSE were calculated by binomial 
regression with a log link. Exploratory investigations of 
confounding and interacting factors were assessed with 
Mantel-Haenszel methods. Risk factors were entered 
into a multivariable model with a forward stepwise 
approach on the basis of the strength of the univariate 
associations. A likelihood ratio test was used to compare 
models. All variables with p<0·25 in an unadjusted 
univariate analysis and no interaction terms were 
included in the multivariable model; only those with 
p<0·05 were retained in the model. We decided a priori 
to include acute bacterial meningitis in each model 
because it is a direct CNS infection. We estimated 
unadjusted eﬀ ects for all available data, and multivariable 
analyses were done for children for whom complete data 
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had been collected. Children who did not survive to 
discharge were excluded from the analysis of sequelae. 
This study was approved by the National Ethics 
Committee of Kenya, and parents gave consent for study 
staﬀ  to interview them and examine their children as part 
of the follow-up study.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication. 
Results
The ﬁ gure shows the study design and proﬁ le. In the 
2-year study period, 2837 (27%) of all children admitted 
to KDH were admitted with seizures. We obtained 
hospital records for 2585 (91%) children, 388 of whom 
had at least one episode of CSE. Of these children, 
155 (40%) had conﬁ rmed CSE, and 233 (60%) had 
probable CSE. 17 recorded episodes of CSE in children 
who had multiple episodes were excluded from analysis.
Table 1 shows the demographic and clinical features of 
all children admitted with CSE, and criteria used to 
diagnose probable CSE. 274 (71%) cases had an infective 
cause. 253 (65%) children had a positive malaria slide, 
and malaria was the primary diagnosis for 206 (53%) 
children. 41 (11%) children had bacteraemia and 33 (9%) 
had acute bacterial meningitis. Seizures had a focal onset 
in 151 (39%) children, and hypoglycaemia (blood glucose 
<2·5 mmol/L) was detected in 41 (11%) children.
59 (15%) children died in hospital, 28 (47%) of these 
within 24 h of admission and 44 (75%) within 48 h; 
81 (21%) died during the following 3 years. 46 (12%) 
children had neurological sequelae at discharge. Motor 
deﬁ cits were the most common disorder, aﬀ ecting 
40 (87%) children who had sequelae. Death before 
discharge was more common in children with 
conﬁ rmed CSE than in those with probable CSE (table 1; 
diﬀ erence between groups 13%, 95% CI 6–21; p=0·0003). 
2837 children admitted to KDH with seizures 
            in 2002 and 2003
2197 not judged to have CSE
252 hospital records not obtained
388 conﬁrmed or probable CSE*
59 died in hospital
329 discharged home
175 outside DSS
154 discharged to DSS
16 data not available
138 followed-up 3 years after discharge
Conﬁ rmed CSE 
(n=155)
Probable CSE 
(n=233)
Inclusion criteria for probable CSE
Convulsions on arrival to hospital ·· 180 (77%)
Phenytoin or phenobarbital to stop seizures ·· 48 (21%)
Coma on admission, >1 seizure in previous 30 min ·· 1 (<1%)
Coma on admission, >10 seizures in previous 24 h ·· 4 (2%)
Demographic characteristics
Age <12 months 29 (19%) 48 (21%)
Male 76 (49%) 113 (48%)
Clinical history
History of any seizures 36 (23%) 83 (36%)
Presented during ﬁ rst seizure of illness 23 (15%) 68 (29%)
Focal onset seizure 77 (50%) 74 (32%)*
Received >2 antiepileptic drugs during CSE 63 (41%) 5 (2%)
Physical ﬁ ndings during CSE
Malnutrition (WHZ <–2) 50 (32%)† 70 (30%)‡
Fever (axillary temperature ≥38·0°C) 74 (48%) 105 (45%)§
Hypoxia (oxygen saturation <92%) 108 (70%) 94 (40%)*
Laboratory parameters
Hypoglycaemia (blood glucose <2·5 mmol/L) 18 (12%) 23 (10)¶
Severe anaemia (haemoglobin <50 g/L) 14 (9%) 21 (9%)||
Positive malaria slide 101 (65%) 152 (65%)
Bacteraemia 23 (15%) 18 (8%)**
Lumbar puncture done 136 (88%) 179 (77%)
Acute bacterial meningitis 20 (13%)†† 13 (6%)‡‡
Primary diagnosis
Malaria without febrile convulsion 49 (32%) 65 (28%)
Febrile convulsion secondary to malaria 35 (23%) 57 (24%)
Febrile convulsion secondary to other infection 3 (2%) 11 (5%)
Acute bacterial meningitis 15 (10%) 16 (7%)
Other infection without febrile convulsion 10 (6%) 13 (6%)
Encephalopathy of unknown cause 24 (15%) 11 (5%)
Anaemia 11 (7%) 21 (9%)
Epilepsy 2 (1%) 21 (9%)
Outcomes
Died before discharge 36 (23%) 23 (10%)
Neurological sequelae at discharge 28 (18%) 18 (8%)
WHZ=weight-for-height Z score. *4 missing values. †7 missing values. ‡18 missing values. §1 missing value. 
¶5 missing values. ||2 missing values. **1 missing value. ††19 missing values. ‡‡54 missing values. 
Table 1: Characteristics of patients in descriptive analysis
Figure: Study design and proﬁ le
*All 388 CSE cases were used for descriptive analysis. The 178 cases linked to the 
DSS database were used for incidence analysis, and the 155 conﬁ rmed CSE cases 
were used for risk factor analysis.
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The proportion of children who had neurological 
sequelae at discharge was also higher in the group with 
conﬁ rmed CSE than in the group with probable CSE 
(table 1; diﬀ erence between groups 10%, 3–17; 
p=0·0020).
337 children were admitted with their ﬁ rst episode of 
CSE between April 16, 2002, and Dec 31, 2003, and 
178 (53%) of these resided within the DSS area. Of this 
group, 58 (33%) children had conﬁ rmed CSE and 
120 (67%) had probable CSE. Table 2 shows the 
characteristics of this group of children. The mortality or 
development of neurological sequelae on discharge did 
not diﬀ er signiﬁ cantly between children who did or did 
not reside within the DSS area. Table 3 shows the 
incidence of admission to KDH with either conﬁ rmed or 
probable CSE, both overall and broken down by age-
group. The incidence of CSE did not vary signiﬁ cantly by 
sex in any age-group.
The univariate analysis showed that ﬁ ve factors were 
associated with a high risk of mortality in hospital: acute 
bacterial meningitis, hypoglycaemia, age of less than 
12 months, bacteraemia, and focal onset seizures (table 4). 
A positive malaria slide was associated with a low risk of 
mortality in hospital. Factors not associated with mortality 
were sex, history of seizures, malnutrition (weight-for-
height Z score <–2), fever, hypoxia, use of more than two 
antiepileptic drugs, and severe anaemia (haemoglobin 
<50 g/L). Acute bacterial meningitis and focal onset 
seizures were the only signiﬁ cant risk factors for death in 
the multivariable analysis. There was no evidence of an 
interaction between meningitis and focal onset of 
seizures (χ² test of homogeneity p=0·9259). 
Univariate analysis identiﬁ ed three risk factors that were 
associated with an increased of sequelae: hypo glycaemia, 
age less than 12 months, and focal onset seizures (table 4). 
In the multivariable analysis, only hypoglycaemia and age 
less than 12 months were signiﬁ cant risk factors for the 
development of neurological sequelae. 
Data were available for 138 of the 154 (90%) children 
who were discharged from hospital who were residing 
within the DSS area during their admission. 22 (16%) 
died after discharge—18 (82%) of these with seizures as a 
part of their ﬁ nal illness. 15 (11%) children in the DSS 
database had neurological sequelae, with motor and 
speech impairments each aﬀ ecting 11 (7%) children. 
16 (12%) children from this cohort had active epilepsy (at 
least one unprovoked seizure within 1 year of admission).
Discussion
We have shown the incidence of admission to hospital 
with CSE in the Kiliﬁ  district of rural Kenya is more than 
that in London.3 If probable cases are also included, the 
incidence is almost eight times higher than in London. 
Even this higher rate, which is more likely to represent 
the true disease burden than is the rate of conﬁ rmed 
cases alone, might be an underestimate owing to 
incomplete ascertainment, for several reasons. First, 
many children with CSE in this region die without 
reaching hospital, and a few might be treated successfully 
in peripheral clinics. Second, only 178 children could be 
Conﬁ rmed CSE (n=58) Probable CSE (n=120)
Inclusion criteria for probable CSE
Convulsions on arrival to hospital ·· 102 (85%)
Phenytoin or phenobarbital to stop seizures ·· 17 (14%)
Coma on admission, >1 seizure in previous 30 min ·· 0 (0%)
Coma on admission, >10 seizures in previous 24 h ·· 1 (1%)
Demographic characteristics
Age <12 months 7 (12%) 28 (23%)
Male 28 (48%) 55 (46%)
Clinical history
History of any seizures 16 (28%) 35 (29%)
Presented during ﬁ rst seizure of illness 12 (21%) 36 (30%)
Focal onset seizure 33 (57%) 35 (29%)*
Received >2 antiepileptic drugs during CSE 25 (43%) 4 (3%)
Physical ﬁ ndings during CSE
Malnutrition (WHZ <–2) 18 (31%)† 32 (27%)‡
Fever (axillary temperature ≥38·0°C) 24 (41%) 53 (44%)
Hypoxia (oxygen saturation <92%) 38 (66%) 58 (48%)†
Laboratory parameters
Hypoglycaemia (blood glucose <2·5 mmol/L) 5 (9%) 12 (10%)†
Severe anaemia (haemoglobin <50 g/L) 3 (5%) 11 (9%)*
Positive malaria slide 40 (69%) 86 (72%)
Bacteraemia 9 (16%) 5 (4%)†
Lumbar puncture done 52 (90%) 95 (79%)
Acute bacterial meningitis 5 (9%)§ 3 (3%)¶
Primary diagnosis
Malaria without febrile convulsion 21 (36%) 36 (30%)
Febrile convulsion secondary to malaria 13 (22%) 34 (28%)
Febrile convulsion secondary to other infection 2 (3%) 7 (6%)
Acute bacterial meningitis 2 (3%) 4 (3%)
Other infection without febrile convulsion 4 (7%) 2 (2%)
Encephalopathy of unknown cause 8 (14%) 7 (6%)
Anaemia 5 (9%) 13 (11%)
Epilepsy 1 (2%) 5 (4%)
Outcomes
Died before discharge 11 (19%) 13 (11%)
Neurological sequelae at discharge 13 (22%) 8 (7%)
*2 missing values. †1 missing value. ‡ 7 missing values. §6 missing values. ¶25 missing values.
Table 2: Characteristics of patients in incidence analysis
In census (n) Conﬁ rmed CSE All CSE*
Admitted (n) Incidence (95% CI)† Admitted (n) Incidence (95% CI)†
1–11 months 7871 7 52 (21–107) 36 268 (188–371)
12–59 months 30 886 45 85 (62–114) 120 227 (189–272)
60–155 months 57 581 6 6 (2–13) 22 22 (14–34)
All ages 96 338 58 35 (27–46) 178 108 (93–125)
*Conﬁ rmed CSE plus probable CSE. †Incidence per 100 000 child-years.
Table 3: Admission to Kiliﬁ  District Hospital because of CSE
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linked to the DSS database, perhaps because clerical staﬀ  
were unable to obtain accurate residence information 
during the emergency admission—thus, we were able to 
include in our incidence analysis fewer children than 
have other recent studies in this region. Finally, we were 
able to obtain the case notes for only 91% of children 
suspected of having CSE.
Previous studies of CSE in children, most of which 
were done in developed countries, have reported lower 
incidence rates (from 3·8 to 38 per 100 000 per year)4 than 
we recorded in Kenya. Several factors are likely to explain 
this diﬀ erence. The local population has restricted access 
to medical facilities and transport, and treatment before 
admission to hospital is often inadequate. Seizures 
therefore last longer than in developed countries before 
medical care is reached, and are thus more refractory to 
treatment.14 This factor might be more important in other 
regions of Africa, where local epilepsy services are not 
provided as they are in Kiliﬁ . Studies in developed 
countries report an infectious cause in 51–66% of CSE 
cases,15–17 which is lower than our proportion of 71%. In 
light of this link between CSE and infection, these higher 
incidence rates might also reﬂ ect the high prevalence of 
infection in sub-Saharan Africa. Malaria is a common 
cause of childhood infections in this area, and could 
account for much of the greater incidence. 
The inpatient mortality rate in this study is substantially 
higher than that reported in other studies of children. 
The short-term (within 30 days) mortality rate in a recent 
systematic review of population-based studies was 3–9% 
in children.4 Other studies have reported a mortality rate 
in children of up to 11%.18,19 Studies in predominantly 
adult populations describe a mortality rate of 7–46%.20–22 
Mortality was associated with bacterial meningitis, which 
has a worse outcome in this area than in developed 
countries23 and has also been associated with a poor 
outcome in children with CSE.3 Furthermore, most 
children who died did so within 48 h of admission; this 
suggests that interventions to reduce mortality should be 
aimed at the prevention of the major causes of CSE and at 
emergency seizure treatment before hospital admission.
A positive malaria slide was associated with a lower risk 
of mortality in the univariate analysis, possibly because 
children who did not have malaria had CSE with a more 
severe underlying cause, such as encephalitis, which was 
associated with a worse outcome. After adjustment for 
other factors in the multivariable analysis, the presence 
of malaria did not aﬀ ect outcome signiﬁ cantly. 
The proportion of children who had neurological 
sequelae at discharge is lower than in previous studies, 
where neurological sequelae have been reported in 
28–53% of children after CSE,17,18,24–26 and the risk of 
epilepsy after CSE has been estimated at between 
19% and 82%.24,25,27 In this study, children were assessed 
at discharge and no psychomotor testing was done. In a 
previous study in this area of Kenya, 24% of children who 
had complicated seizures associated with malaria in this 
population had neurocognitive impairment 3–9 years 
later.28 The lower rate of sequelae reported here might be 
due to a shorter period of follow-up and a higher mortality 
rate than in some previous studies.
Young age, longer duration of seizure, and acute 
symptomatic causes (ie, an acute underlying illness) have 
previously been associated with mortality and morbidity 
in CSE.4,15–18,25,27,29–33 In this study, focal onset seizures were a 
risk factor for mortality, which suggests an underlying 
preventable cause.34 Age less than 12 months and hypo-
glycaemia were associated with the development of neuro-
logical sequelae, so early detection and rapid correction of 
hypoglycaemia might prevent some of these sequelae. 
The diﬀ erences between the conﬁ rmed CSE and 
probable CSE groups in this study might have been 
caused by time to admission to hospital and other 
immeasurable factors. Analysis of risk factors was 
therefore restricted to children who had conﬁ rmed CSE, 
to identify the most important predictors of outcome. 
Our classiﬁ cation was designed to capture children who 
would otherwise have been missed owing to delayed 
presentation to hospital. In a resource-poor setting, this 
delay means that many children would be expected to 
have a prolonged seizure before their arrival at hospital. 
This suggestion is supported by a recent study of 
prolonged seizures in Malawi, in which the average 
duration of a seizure before hospital treatment was 2 h.35 
Furthermore, in an epidemiological study of epilepsy in 
the same population of children in Kenya, many children 
had a history of CSE lasting many hours.36 This supports 
the inclusion of probable cases to assess the burden of 
CSE, but suggests that children in the conﬁ rmed group 
have more severe illness. 
The incidence of childhood CSE in this region of Kenya 
is higher than reported elsewhere and has a worse 
outcome, resulting in a substantial public health issue. 
Infections such as malaria, inadequate treatment before 
arrival at hospital and diﬃ  culties in reaching hospital 
might have contributed to this high incidence and 
Univariate RR 
(95% CI)
p Adjusted RR 
(95% CI)
p
Mortality
Acute bacterial meningitis* 3·071 (1·60–5·90) 0·0008 2·590 (1·36–4·93) 0·0037
Hypoglycaemia (blood glucose <2·5 mmol/L) 2·537 (1·43–4·50) 0·0014 1·930 (0·97–3·82) 0·5940
Age <12 months 2·146 (1·42–4·25) 0·0013 0·535 (0·14–1·98) 0·3482
Bacteraemia 2·207 (1·24–3·94) 0·0074 1·378 (0·53–3·61) 0·5147
Focal-onset seizure 2·302 (1·22–4·35) 0·0101 2·432 (1·09–5·41) 0·0294
Positive malaria slide 0·382 (0·22–0·68) 0·0010 0·947 (0·37–2·46) 0·9118
Neurological sequelae
Hypoglycaemia (blood glucose <2·5 mmol/L) 3·333 (1·84–6·04) 0·0001 3·525 (1·75–7·10) 0·0004
Age <12 months 2·145 (1·09–4·21) 0·0264 2·473 (1·21–5·05) 0·0130
Focal onset seizure 1·991 (1·02–3·88) 0·0428 1·592 (1·37–2·46) 0·9118
*19 missing values.
Table 4: Signiﬁ cant risk factors for mortality and neurological sequelae following conﬁ rmed CSE
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mortality. Cheap and eﬀ ective antiepileptic drugs such as 
phenobarbital are available, but the withdrawal of 
parenteral phenobarbital by pharmaceutical companies6 
might aggravate the poor outcome of CSE in sub-Saharan 
Africa. Community education, prevention of malaria and 
bacterial meningitis, and treatment of seizures and 
correction of hypoglycaemia in local clinics might improve 
the outcome of children with CSE in future.
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